Generation and partial characterization of melanoma sublines resistant to lymphokine activated killer (LAK) cells. Relevance to doxorubicin resistance
Generation and partial characterization of melanoma sublines resistant to lymphokine activated killer (LAK) cells. Relevance to doxorubicin resistance
复制标题
对淋巴因子激活杀伤 (LAK) 细胞具有抗性的黑色素瘤亚系的产生和部分表征。
DOI:
--
复制
发表时间:
1989
影响因子:
6.4
通讯作者:
G. Parmiani
中科院分区:
文献类型:
--
作者:
L. Rivoltini;C. Gambacorti;R. Supino;G. Parmiani
To see whether a tumor cell population may contain cells resistant to lymphokine‐activated killer (LAK) lymphocytes, cells from a LAK‐sensitive melanoma line (Me 665/2) were co‐cultured with LAKs. Three sublines were obtained after 1, 2 or 3 immunoselection cycles. Immunoselected (IS) sublines show reduced proliferation, decreased reactivity to the monoclonal antibody (MAb) R24 and appeared morphologically more differentiated in comparison with the parental Me 665/2 line. A progressively reduced sensitivity to LAKs was observed in IS sublines with a more than 8‐fold reduction in LAK susceptibility. A reduced complement (C)‐mediated lysis was also observed in IS sublines. Since we have previously shown that LAK sensitivity of melanoma cells may be associated with Doxorubicin (Dx) resistance, the sensitivity to Dx was tested in these lines. An augmented sensitivity to Dx was noted in IS sublines as compared with Me 665/2. The differences in LAK susceptibility between the IS sublines and the parental Me 665/2 line remained stable for 2 weeks but declined and disappeared thereafter. These results indicate that (1) a LAK‐sensitive tumor line may contain a subpopulation of cells which are significantly less lysed by LAKs; (2) a correlation between LAK sensitivity and susceptibility to C‐mediated lysis is also present; and (3) increased sensitivity to Dx is evident in the IS sublines.
登录
查看更多内容
DOI:
--
发表时间:
1987-05
期刊:
Laboratory investigation; a journal of technical methods and pathology
影响因子:
--
作者:
M. Herlyn;W. Clark;U. Rodeck;M. Mancianti;J. Jambrosic;H. Koprowski
通讯作者:
M. Herlyn;W. Clark;U. Rodeck;M. Mancianti;J. Jambrosic;H. Koprowski
影响因子:
11.2
作者:
MeyskensJr,FL;Thomson,SP;Moon,TE
通讯作者:
Moon,TE
影响因子:
11.2
作者:
Salup,RR;Wiltrout,RH
通讯作者:
Wiltrout,RH
DOI:
--
发表时间:
1986
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Thompson,JA;Peace,DJ;Klarnet,JP;Kern,DE;Greenberg,PD;Cheever,MA
通讯作者:
Cheever,MA